NCT02174666View on ClinicalTrials.gov

Isoflavone Treatment for Postmenopausal Osteopenia.

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions
OsteopeniaOsteoporosis
Interventions
DIETARY_SUPPLEMENT

Red clover extract

Aglycone isoflavones 80mg/d

DIETARY_SUPPLEMENT

Supplementation (placebo)

Trial Locations (1)

8000

Aarhus University Hospital, Aarhus

All Listed Sponsors
collaborator

European Regional Development Fund

OTHER

collaborator

The Ministry of Science, Technology and Innovation, Denmark

OTHER_GOV

lead

University of Aarhus

OTHER

NCT02174666 - Isoflavone Treatment for Postmenopausal Osteopenia. | Biotech Hunter | Biotech Hunter